AGP Picks
View all

Regional Health Properties Reports Third Quarter 2026 Results

News originally published by

GlobeNewswire

  • Portfolio Occupancy Reached 76%, an 870-Basis-Point Year-Over-Year Improvement
  • Reported revenue of $25.0 million, an increase of 65.2% compared to third quarter 2025
  • Adjusted EBITDA¹ of $1.2 million, an increase of 365% compared to third quarter 2025

ATLANTA, GA, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company,” “Regional,” “we,” “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ), a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services, today announced its financial results for the third quarter ended September 30, 2026.

Third Quarter 2026 Financial Results

  • Reported revenue of $25.0 million, compared with $15.1 million for the third quarter of 2025
  • Reported GAAP net loss of $0.9 million, compared with GAAP net income of $3.7 million for the third quarter of 2025
  • Generated Adjusted EBITDA from operations of $1.2 million, compared with $0.2 million for the third quarter of 2025
  • Reported net loss attributable to common stockholders of $0.22 per share, compared with $1.17 per share for the third quarter of 2025

Third Quarter 2026 Business Highlights

  • Pharmacy Services revenue was $9.5 million following the addition of the Pharmacy Services segment in connection with the SunLink merger
  • Patient care revenues increased to $14.7 million, driven primarily by the transition of facilities to the Healthcare Services segment and higher census across the portfolio
  • Portfolio occupancy was 76.0% at September 30, 2026 vs. 67.3% at September 30, 2025
  • Repurchased 15,829 shares of the Company’s 12.5% Series B Cumulative Redeemable Preferred Shares during the quarter at a discount to carrying value
  • Continued to evaluate refinancing and liquidity alternatives, including potential refinancing of the Southland facility and other mortgage loans

Management Comments

Brent Morrison, Regional’s President, Chief Executive Officer and Chairman, commented, “We are very pleased with our third quarter results, which reflect continued operating improvements and meaningful progress in our transformation from a traditional healthcare real estate landlord into an integrated healthcare company. Our improving financial performance provides growing evidence that our expanded business model is beginning to deliver on its potential. By taking a more active role in facility operations, we are capturing a greater share of the underlying economics of our healthcare assets while creating additional opportunities to improve operational efficiency and profitability.”

Mr. Morrison continued, “While we are encouraged by the operating momentum, we recognize there is more work ahead. Our focus is on improving facility-level profitability, optimizing our Pharmacy and DME operations, and translating stronger operating earnings into sustainable free cash flow. At the same time, we continue to pursue refinancing opportunities that would provide greater financial flexibility to support our operating momentum and strategic growth initiatives.”

1 Adjusted EBITDA is a non-GAAP financial measure. See “Use of Non-GAAP Financial Measures” for important additional information.

Balance Sheet And Liquidity

As of September 30, 2026, the Company had $1.7 million of unrestricted cash and $3.2 million of restricted cash. As of September 30, 2026, the Company had $42.2 million of indebtedness, net of deferred financing costs and unamortized discounts.

About Regional Health Properties, Inc.

Regional Health Properties, Inc. is a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services. For more information, visit https://www.regionalhealthproperties.com.

Important Cautions Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “expects,” “intends,” “believes,” “anticipates,” “plans,” “likely,” “will,” “seeks,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. This press release includes forward-looking statements that reflect the Company’s current views with respect to, among other things, its business, operations, financial performance, liquidity, capital resources, refinancing alternatives, facility operations, pharmacy operations, and future strategy.

Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or contemplated by our forward-looking statements due to various factors, including, among others: the operating performance of our Healthcare Services and Pharmacy Services segments; our ability to collect patient, pharmacy and rent receivables; our dependence on the operating success of our tenants and managers; our ability to service our indebtedness and comply with covenants; the availability and cost of capital; our ability to refinance indebtedness, raise capital or complete asset sales on acceptable terms; changes in reimbursement rates and healthcare regulation; pharmacy reimbursement and claims-processing risk; labor costs, staffing availability and union-related matters; regulatory survey and compliance matters; inflation and interest rates; litigation and insurance costs; the relatively illiquid nature of real estate investments; and other factors discussed from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These forward-looking statements speak only as of the date of this press release, and we expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, except to the extent otherwise required by applicable law.

Company Contact
Brent Morrison, CFA
Chief Executive Officer & President
Regional Health Properties, Inc.
Tel (678) 368-4402
Brent.morrison@regionalhealthproperties.com


REGIONAL HEALTH PROPERTIES, INC.
STATEMENT OF OPERATIONS
(in thousands)
             
    Three Months Ended September 30,  
    2026     2025  
    (Unaudited)        
Revenues:            
Patient care revenues   $ 14,714     $ 9,831  
Rental revenues     798       1,303  
Pharmacy revenues     9,502       4,004  
Total revenues     25,014       15,138  
Expenses:                
Cost of goods sold     5,838       2,470  
Patient care expense     11,035       8,639  
Facility rent expense     248       197  
Depreciation and amortization     785       547  
General and administrative expense     6,570       3,713  
Credit loss expense     210       166  
Total expenses, excluding impairment     24,686       15,732  
Impairment loss on assets held for sale     459       —  
Loss from operations     (131 )     (594 )
Other expense:                
Interest expense, net     576       751  
Loss (gain) on bargain purchase     78       (5,311 )
Loss on disposal of assets     11       —  
Other (income) expense, net     83       584  
Total other (income) expense, net     748       (3,976 )
Net loss     (879 )     3,382  
Deemed contribution related to Preferred Series B purchases     28       278  
Net loss attributable to Regional Health Properties, Inc. common stockholders   $ (851 )   $ 3,660  
Net loss per share of common stock attributable to Regional Health Properties, Inc.:                
Basic and Diluted   $ (0.22 )   $ 1.17  
Weighted average shares of common stock outstanding:                
Basic and Diluted     3,925       3,125  


REGIONAL HEALTH PROPERTIES, INC.
BALANCE SHEET
(in thousands)
             
      9/30/2026       12/31/2025  
      (Unaudited)          
ASSETS                
Cash   $ 1,651     $ 3,013  
Restricted cash     2,243       1,631  
Accounts receivable, net of allowances of $933 and $727     10,643       8,025  
Inventory     1,464       1,354  
Notes receivable     564       644  
Prepaid expenses and other     1,413       1,623  
Total current assets     17,978       16,290  
Property and equipment, net     35,025       35,805  
Assets held for sale, net     3,811       4,207  
Restricted cash     999       1,420  
Intangible assets     4,584       4,660  
Other assets     3,521       3,842  
Goodwill     1,585       1,585  
Total assets   $ 67,503     $ 67,809  
LIABILITIES AND EQUITY                
Accounts payable   $ 7,819     $ 6,986  
Accrued expenses     9,792       7,888  
Other liabilities     2,035       867  
Debt related to assets held for sale, net     3,027       3,001  
Current portion of long term debt     5,319       5,414  
Total current liabilities     27,992       24,156  
Long-term debt, net - less current maturities     33,845       34,738  
Operating lease obligation     2,040       2,325  
Other liabilities     1,544       1,550  
Total liabilities     65,421       62,769  
Preferred stock, Series D, no par values, 1,420 shares authorized; 1,406 shares issued and outstanding at September 30, 2026 and December 31, 2025.     4,691       4,691  
Stockholders' equity:                
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 3,936 issued and 3,925 outstanding at September 30, 2026 and 3,946 issued and 3,935 outstanding at December 31, 2025.     67,550       67,296  
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A, Series B and Series D); shares issued and outstanding designated separately                
Preferred stock, Series A, no par value; 560 shares authorized, issued and outstanding at September 30, 2026 and December 31, 2025, with a redemption amount $426 at September 30, 2026 and December 31, 2025     426       426  
Preferred stock, Series B, no par value; 2,812 shares authorized; 1,690 and 1,741 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively, with a redemption amount $13,960 and $14,382 at September 30, 2026 and December 31, 2025, respectively     13,960       14,382  
Accumulated deficit     (84,567 )     (81,777 )
 Accumulated other comprehensive earnings     22       22  
Total stockholders' equity (deficit)     (2,609 )     349  
Total liabilities, Series D preferred stock and stockholders' equity (deficit)   $ 67,503     $ 67,809  


REGIONAL HEALTH PROPERTIES, INC.
DEBT SUMMARY
(in thousands)
   
                      9/30/2026 
      Maturity       Interest Rate       Principal       % of Principal       Deferred financing costs       Unamortized discount on bonds       Net Carrying Value  
                                                         
Total Fixed Rate Debt     05/29/33       4.35 %     36,204       84.3 %     (615 )     (96 )     35,493  
                                                         
Total Floating Rate Debt     10/01/36       8.67 %     6,763       15.7 %     (65 )     -       6,698  
                                                         
Total                   $ 42,967       100.0 %   $ (680 )   $ (96 )   $ 42,191  


REGIONAL HEALTH PROPERTIES, INC.
RECONCILIATION OF NET (LOSS) TO NON-GAAP FINANCIAL MEASURES
(in thousands)
             
    Three Months Ended September 30,  
    2026     2025  
    (Unaudited)        
             
Net income (loss)   $ (879 )   $ 3,382  
Depreciation and amortization     785       547  
Interest expense, net     576       751  
EBITDA     482       4,680  
Amortization of employee stock compensation     85       124  
Loss (gain) from bargain purchase     78       (5,311 )
Loss on disposal of assets     11       0  
Other (income) expense, net     —       584  
Impariment loss on assets held for sale     459       0  
Other one-time income     35       170  
Adjusted EBITDA from operations   $ 1,150     $ 247  



Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Mexico Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.